(15 November 2023, Hong Kong) HKSH Medical Group (HKSH), LKS Faculty of Medicine of the University of Hong Kong (HKUMed), and the Hong Kong Hereditary Breast Cancer Family Registry (Registry) today announced significant findings from their collaborative research studies on the germline mutation landscape of nearly 4,900 individuals with hereditary breast and/or ovarian cancers in Hong Kong. This pioneering collaboration, ongoing since 2007, aims to facilitate early detection of and targeted treatment strategies on breast and ovarian cancers among high-risk groups and their families.

Please click here for more information.